首頁 > 市場調查報告書 > 製藥

藥物開發臨床實驗臨床開發

市場調查報告書

商品編碼

1542510

全球臨床試驗管理系統 (CTMS) 市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Clinical Trials Management System (CTMS) Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球臨床試驗管理系統（CTMS）市場需求預計將從2023年的23.3億美元達到2032年近84.2億美元的市場規模，2024-2032年研究期間複合年成長率為15.32%。

臨床試驗是指評估新藥、治療方法、醫療器材或介入措施對人類參與者的功效、安全性和有效性的系統性研究。這些試驗對於推進醫學知識、開發新療法以及在向公眾提供治療之前評估潛在風險和益處至關重要。這些研究遵循監管機構制定的嚴格協議和指南，以確保道德行為、參與者安全和可靠的資料收集。它們通常分階段進行，從健康志願者的小規模研究（第一階段）到患者族群的大規模試驗（第二階段和第三階段），最終進入監管審查和批准流程。

市場動態

慢性病的流行、人口老化以及對個人化醫療的需求推動了對透過臨床試驗評估的新療法和治療方案的需求。製藥和生物技術公司、學術機構和政府機構投資臨床研究，以滿足未滿足的醫療需求並改善患者的治療效果。生物技術、基因組學和精準醫學技術的進步加速了試驗設計和執行，支持標靶治療和生物標記驅動的方法。現實世界證據 (RWE) 與穿戴式裝置和遠端監控設備等數位健康技術的整合可提高試驗效率、資料品質和患者參與度，促進分散試驗模型和自適應試驗設計。

此外，監管改革和簡化臨床試驗流程和加快藥物核准時間表的措施促進了臨床研究的創新和投資。行業利益相關者、患者倡導團體和監管機構之間的合作可促進透明度、資料共享和以患者為中心的試驗設計，從而提高招募率和保留率。為因應 COVID-19 大流行，採用虛擬和混合試驗模型推動了試驗實施和參與者訪問方面的創新，為更靈活、更有彈性的臨床試驗生態系統鋪平了道路。然而，試驗成本高、招募和保留不同患者群體以及不同地區監管複雜性等挑戰可能會阻礙臨床試驗市場的成長。

市場區隔

臨床試驗管理系統 (CTMS) 市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按解決方案類型

企業
地點

按組件

軟體
服務

按交付方式

網路和雲端
內部部署

按最終用戶

製藥和生物技術公司
醫療器材公司
CRO 及其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲臨床試驗管理系統 (CTMS) 市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。臨床試驗管理系統 (CTMS) 市場的主要參與者包括 IQVIA Inc.、Medidata (Dassault SysteMes)、Oracle、Datatrak International Inc.、Clario、SimpleTrials、Calyx（原 Parexel Informatics）、RealTime Software Solutions LLC、Laboratory Corporation Of America Holdings、Veeva Systems、Wipro、Pharmaseal International Ltd。和其他開發。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按解決方案類型進行的市場吸引力分析
- 按組件分類的市場吸引力分析
- 按交付模式分類的市場吸引力分析
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球臨床試驗管理系統 (CTMS) 市場分析：按解決方案類型

按解決方案類型概述
按解決方案類型進行歷史和預測資料分析
企業
地點

第 6 章：全球臨床試驗管理系統 (CTMS) 市場分析：按組成部分

按組件概述
按組成部分的歷史和預測資料分析
軟體
服務

第 7 章：全球臨床試驗管理系統 (CTMS) 市場分析：依交付模式

按交付模式概述
按交付模式進行歷史和預測資料分析
網路和雲端
內部部署

第 8 章：全球臨床試驗管理系統 (CTMS) 市場分析：按最終用戶

最終用戶概述
最終用戶的歷史和預測數據分析
製藥和生物技術公司
醫療器材公司
CRO 及其他

第 9 章：全球臨床試驗管理系統 (CTMS) 市場分析：按地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：臨床試驗管理系統 (CTMS) 公司的競爭格局

臨床試驗管理系統（CTMS）市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
IQVIA Inc.

公司概況
公司收入
產品
最新動態

Medidata (Dassault SysteMes)

公司概況
公司收入
產品
最新動態

Oracle

公司概況
公司收入
產品
最新動態

Datatrak International Inc.

公司概況
公司收入
產品
最新動態

Clario

公司概況
公司收入
產品
最新動態

SimpleTrials

公司概況
公司收入
產品
最新動態

Calyx (Formerly Parexel Informatics)

公司概況
公司收入
產品
最新動態

RealTime Software Solutions LLC

公司概況
公司收入
產品
最新動態

Laboratory Corporation Of America Holdings

公司概況
公司收入
產品
最新動態

Veeva Systems

公司概況
公司收入
產品
最新動態

Wipro

公司概況
公司收入
產品
最新動態

Pharmaseal International Ltd

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11210452

The global demand for Clinical Trials Management System (CTMS) Market is presumed to reach the market size of nearly USD 8.42 Billion by 2032 from USD 2.33 Billion in 2023 with a CAGR of 15.32% under the study period 2024-2032.

Clinical trials refer to systematic studies that evaluate the efficacy, safety, and effectiveness of new drugs, treatments, medical devices, or interventions on human participants. These trials are crucial for advancing medical knowledge, developing new therapies, and assessing potential risks and benefits before treatments are made available to the public. These studies follow strict protocols and guidelines established by regulatory authorities to ensure ethical conduct, participant safety, and reliable data collection. They typically progress through phases, from small-scale studies in healthy volunteers (Phase 1) to large-scale trials in patient populations (Phase 2 and Phase 3), culminating in regulatory review and approval processes.

MARKET DYNAMICS

The propelling prevalence of chronic diseases, aging populations, and demand for personalized medicine drive the need for new therapies and treatment options evaluated through clinical trials. Pharmaceutical and biotechnology companies, academic institutions, and government agencies invest in clinical research to address unmet medical needs and enhance patient outcomes. Advancements in biotechnology, genomics, and precision medicine technologies accelerate trial design and execution, supporting targeted therapies and biomarker-driven approaches. Integration of real-world evidence (RWE) and digital health technologies such as wearables & remote monitoring devices enhance trial efficiency, data quality, and patient engagement, facilitating decentralized trial models and adaptive trial designs.

Moreover, regulatory reforms and initiatives to streamline clinical trial processes and accelerate drug approval timelines foster innovation and investment in clinical research. Collaboration between industry stakeholders, patient advocacy groups, and regulatory agencies promotes transparency, data sharing, and patient-centered trial designs, improving recruitment and retention rates. The adoption of virtual and hybrid trial models in response to the COVID-19 pandemic drives innovation in trial conduct and participant access, paving the way for more flexible and resilient clinical trial ecosystems. However, challenges such as high trial costs, recruitment and retention of diverse patient populations, and regulatory complexities across different regions may hinder clinical trial market growth.

MARKET SEGMENTATION

This section of the Clinical Trials Management System (CTMS) market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Solution Type

Enterprise
Site

By Component

Software
Services

By Delivery Mode

Web & Cloud Based
On Premise

By End-user

Pharmaceutical and Biotechnology Firms
Medical Device Firms
CROs & Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Clinical Trials Management System (CTMS) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Clinical Trials Management System (CTMS) market include IQVIA Inc., Medidata (Dassault SysteMes), Oracle, Datatrak International Inc., Clario, SimpleTrials, Calyx (Formerly Parexel Informatics), RealTime Software Solutions LLC, Laboratory Corporation Of America Holdings, Veeva Systems, Wipro, Pharmaseal International Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Solution Type
- 3.7.2 Market Attractiveness Analysis By Component
- 3.7.3 Market Attractiveness Analysis By Delivery Mode
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY SOLUTION TYPE

5.1. Overview By Solution Type
5.2. Historical and Forecast Data Analysis By Solution Type
5.3. Enterprise Historic and Forecast Sales By Regions
5.4. Site Historic and Forecast Sales By Regions

6. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY COMPONENT

6.1. Overview By Component
6.2. Historical and Forecast Data Analysis By Component
6.3. Software Historic and Forecast Sales By Regions
6.4. Services Historic and Forecast Sales By Regions

7. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY DELIVERY MODE

7.1. Overview By Delivery Mode
7.2. Historical and Forecast Data Analysis By Delivery Mode
7.3. Web & Cloud Based Historic and Forecast Sales By Regions
7.4. On Premise Historic and Forecast Sales By Regions

8. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data Analysis By End-user
8.3. Pharmaceutical and Biotechnology Firms Historic and Forecast Sales By Regions
8.4. Medical Device Firms Historic and Forecast Sales By Regions
8.5. CROs & Others Historic and Forecast Sales By Regions

9. GLOBAL CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) COMPANIES

10.1. Clinical Trials Management System (CTMS) Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CLINICAL TRIALS MANAGEMENT SYSTEM (CTMS) INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. IQVIA Inc.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Medidata (Dassault SysteMes)
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Oracle
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Datatrak International Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Clario
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. SimpleTrials
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Calyx (Formerly Parexel Informatics)
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. RealTime Software Solutions LLC
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Laboratory Corporation Of America Holdings
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Veeva Systems
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Wipro
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Pharmaseal International Ltd
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Solution Type (USD MN)
Enterprise Market Sales By Geography (USD MN)
Site Market Sales By Geography (USD MN)
Analysis By Component (USD MN)
Software Market Sales By Geography (USD MN)
Services Market Sales By Geography (USD MN)
Analysis By Delivery Mode (USD MN)
Web & Cloud Based Market Sales By Geography (USD MN)
On Premise Market Sales By Geography (USD MN)
Analysis By End-user (USD MN)
Pharmaceutical and Biotechnology Firms Market Sales By Geography (USD MN)
Medical Device Firms Market Sales By Geography (USD MN)
CROs & Others Market Sales By Geography (USD MN)
Global Clinical Trials Management System (CTMS) Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition